Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.

Cristina Gasparetto, MD, Jon P Gockerman, Louis F Diehl, MD, Carlos de Castro, III, MD, Joseph O Moore, Gwynn D Long, Mitchell Horwitz, MD, John Chute, MD, Keith M Sullivan, MD, Rachel Neuwirth, Patricia H Davis, Linda M. Sutton, Russell D Anderson, Nelson Chao, David A. Rizzieri, MD

Blood (2008) 112 (11): 3325.

https://doi.org/10.1182/blood.V112.11.3325.3325

Published: 2008

Journal Articles

Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.

Kevin H.M. Kuo, MD, Jeannie Callum, M.D., FRCPC, Joseph Brandwein, M.D., FRCPC, Michael Crump, M.D., FRCPC, John E. Curtis, M.D., FRCPC, Vikas Gupta, M.D., MRCP, Jeffrey H. Lipton, M.D., Ph.D., FRCPC, Dominic Pantalony, M.D., FRCPC, Aaron Schimmer, M.D., FRCPC, Andre Schuh, M.D., FRCPC, Graham Sher, M.D., Ph.D., FRCPC, David M. Sutton, M.D., FRCPC, Karen W.L. Yee, M.D., FRCPC, Armand Keating, M.D., FRCPC, Mark D. Minden, M.D., Ph.D., FRCPC, Hans A. Messner, M.D., Ph.D., FRCPC

Blood (2006) 108 (11): 2007.

https://doi.org/10.1182/blood.V108.11.2007.2007

Published: 2006

Journal Articles

A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.

Kathryn E. Webert, MD, Richard J. Cook, PhD, Morris A. Blajchman, MD, Stephen Couban, MD, David M. Sutton, MD, Jeffrey H. Lipton, MD, Julie Carruthers, Joseph Brandwein, MD, Nancy M. Heddle, MSc, FCMLS(D)

Blood (2005) 106 (11): 4183.

https://doi.org/10.1182/blood.V106.11.4183.4183

Published: 2005

Journal Articles

A Randomised Controlled Trail of Plasma Exchange in Rapidly Progressive Renal Failure of Myeloma.

William F. Clark, MD, A. Keith Stewart, MD, Gail A. Rock, MD, Marion Sternbach, MD, David M. Sutton, MD, Brendan J. Barrett, MD, Paul A. Heidenheim, MA, David N. Churchill, MD, members of the Canadian Apheresis Group

Blood (2004) 104 (11): 4899.

https://doi.org/10.1182/blood.V104.11.4899.4899

Published: 2004

Journal Articles

Negative Impact of Pre-Transplant Anemia on Long-Term Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Chris Lazongas, BSc, Cindy J. Wong, MSc, David M. Sutton, MD, Jeffrey H. Lipton, MD PhD, Anargyros Xenocostas, MD, Hans A. Messner, MD PhD

Blood (2004) 104 (11): 1844.

https://doi.org/10.1182/blood.V104.11.1844.1844

Published: 2004

Journal Articles

The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients

RL Nagel, S Erlingsson, ME Fabry, H Croizat, SM Susuka, H Lachman, M Sutton, C Driscoll, E Bouhassira, HH Billett

Blood (1991) 77 (6): 1371–1375.

https://doi.org/10.1182/blood.V77.6.1371.1371

Published: 1991

NARROW

Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.

Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.

A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.

A Randomised Controlled Trail of Plasma Exchange in Rapidly Progressive Renal Failure of Myeloma.

Negative Impact of Pre-Transplant Anemia on Long-Term Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients

Email alerts

ASH Publications

American Society of Hematology

Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.

Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.

A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.

A Randomised Controlled Trail of Plasma Exchange in Rapidly Progressive Renal Failure of Myeloma.

Negative Impact of Pre-Transplant Anemia on Long-Term Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only